目的:本研究的目的是确定癌症患者对抗COVID-19疫苗的态度。
背景:历史上,科学界的责任是调查对疫苗接种的态度。COVID-19在癌症患者中的病程使他们成为疫苗接种的高度优先事项。由于COVID-19感染,癌症患者发生严重并发症和死亡的风险更大。
目的:本研究的目的是确定癌症患者对抗COVID-19疫苗的态度。我们检查了几种可能影响癌症患者对疫苗看法的结构:健康状况,COVID-19和疫苗接种知识,癌症患者对脆弱性的看法,以及对一般疫苗的态度。
方法:我们对200名接受治疗的癌症患者进行了集体案例研究,并将样本分为两组:“预期治愈”的患者(A组)和“预期慢性化”的患者(B组)。数据是通过专门构建的问卷收集的,问卷由22个问题和一份医疗记录研究组成。
结果:数据分析显示两组,A组(M=3.89SD=0.64)和B组(M=3.98SD=0.64),对抗COVID-19疫苗持有利态度。这种对抗COVID-19疫苗的有利态度取决于几个因素:对COVID-19的脆弱性的感知,对其肿瘤状况的严重程度的感知,以及与肿瘤学家的沟通。
结论:我们的研究强调了影响抗COVID-19疫苗态度的多种因素。因此,增加使用共享决策方法(SDM)来指导患者做出明智的选择至关重要。
OBJECTIVE: The purpose of the present study was to determine cancer patients\'
attitudes toward the anti-COVID-19 vaccine.
BACKGROUND: Historically, the scientific community\'s responsibility was to investigate
attitudes about vaccination. The course of COVID-19 in cancer patients makes them a high priority for vaccination. Cancer patients are at greater risk of serious complications and death because of COVID-19 infection.
OBJECTIVE: The purpose of the present study was to determine cancer patients\'
attitudes toward the anti-COVID-19 vaccine. We examined several constructs that potentially influenced cancer patients\' perceptions of the vaccine: health status, knowledge of COVID-19 and vaccination, cancer patients\' perceptions of vulnerability, and attitudes toward general vaccines.
METHODS: We conducted a collective
case study with 200 cancer patients undergoing treatment, and divided the sample into two groups: patients who \"expected to heal\" (Group A) and patients who \"expected to chronicize\" (Group B). Data were collected through a purpose-built questionnaire consisting of 22 questions and a study of medical records.
RESULTS: Data analysis showed that both groups, Group A (M= 3.89 SD= 0.64) and Group B (M= 3.98 SD= 0.64), had a favorable attitude toward the anti-COVID-19 vaccine. This favorable attitude toward the anti-COVID-19 vaccine depended on several factors: perception of vulnerability to COVID-19, perception of the severity of their oncological situation, and communication with oncologists.
CONCLUSIONS: Our study highlighted the plurality of factors that influence
attitudes toward the anti-COVID-19 vaccine. It is therefore of fundamental importance to increase the use of the shared decision-making approach (SDM) to guide the patient to an informed choice.